Portfolio Holdings Detail for ISIN IE00B14X4M10

Stock Name / Fund	iShares MSCI North America UCITS ETF USD (Dist) USD
Issuer	Blackrock
Entity holding fund	iShares Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300YDM1GFZR5B4U80
ETF Ticker	IDNA(USD) LSE
ETF Ticker	IQQN(EUR) F
ETF Ticker	IDNA.LS(USD) CXE
ETF Ticker	INAA.LS(GBX) CXE
ETF Ticker	INAA.MI(EUR) CXE
ETF Ticker	INAAz(USD) CXE
ETF Ticker	IQQN.DE(EUR) CXE
ETF Ticker	INAA(EUR) ETF Plus
ETF Ticker	IDNA.L(GBP) LSE

Holdings detail for MRK

Show aggregate MRK holdings

News associated with MRK

Surprising Analyst 12-Month Target For FDL

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 08:04:45

IWD, JNJ, MCD, MRK: Large Inflows Detected at ETF

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Value ETF (Symbol: IWD) where we have detected an approximate $565.9 million dollar inflow -- that's a 0.9% increase week over w - 2025-09-18 13:26:06

Daiichi Sankyo, Merck Say Raludotatug Deruxtecan Granted Breakthrough Therapy Designation

(RTTNews) - Daiichi Sankyo Company Limited (DSKYF) and Merck & Co Inc. (MRK) said on Monday that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for their raludotatug deruxtecan for the treatment of adults with platinum-resistant epithelia - 2025-09-15 08:43:59

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-12 10:32:51

Guru Fundamental Report for MRK - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-11 10:33:21

Notable ETF Inflow Detected - VYM, JNJ, MRK, CME

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard High Dividend Yield ETF (Symbol: VYM) where we have detected an approximate $440.7 million dollar inflow -- that's a 0.7% increase week over - 2025-09-10 11:50:46

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-10 10:34:14

Daiichi Sankyo And Merck : Ifinatamab Deruxtecan Shows Promising Results In Phase 2 ES-SCLC Trial

(RTTNews) - Daiichi Sankyo (DSKYF, 4568.T) and Merck & Co Inc. (MRK) announced that Results from the IDeate-Lung01 phase 2 trial showed that ifinatamab deruxtecan (I-DXd) demonstrated clinically meaningful response rates in patients with previously treated extensive-stage small c - 2025-09-08 02:18:22

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-05 10:33:56

Pre-Market Most Active for Sep 5, 2025 : OPEN, TSLL, SCAG, SQQQ, MRK, NVDA, KO, AVGO, SNAP, FIG, WMT, NIO

The NASDAQ 100 Pre-Market Indicator is up 147.96 to 23,780.97. The total Pre-Market volume is currently 100,628,631 shares traded.The following are the most active stocks for the pre-market session: Opendoor Technologies Inc (OPEN) is +0.27 at $6.23, with 12,819,663 shares trade - 2025-09-05 09:29:53

Guru Fundamental Report for MRK - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-04 10:32:25

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-03 10:34:47

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-29 10:33:23

MRK's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow'

Merck & Co Inc (Symbol: MRK) has been named as the ''Top Dividend Stock of the Dow'', according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among the components of the Dow Jones Industrial Average, MRK shares displayed b - 2025-08-28 08:50:04

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-27 10:34:49

MRK Quantitative Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-26 10:34:02

iShares MSCI ACWI ETF Experiences Big Outflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $429.5 million dollar outflow -- that's a 1.9% decrease week over week (f - 2025-08-25 13:36:45

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-22 10:34:21

Dow Movers: WMT, MRK

In early trading on Thursday, shares of Merck topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.2%. Year to date, Merck has lost about 13.8% of its value. And the worst performing Dow component thus far on the day is Walmart, tr - 2025-08-21 11:27:42

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-20 10:34:00

After Hours Most Active for Aug 19, 2025 : CSX, INTC, MRK, NVDA, IBN, KO, FUN, PEP, CX, WMT, HTZ, QQQ

The NASDAQ 100 After Hours Indicator is down -1.71 to 23,383.06. The total After hours volume is currently 259,932,235 shares traded.The following are the most active stocks for the after hours session: CSX Corporation (CSX) is -0.04 at $36.48, with 11,794,785 shares traded. Ove - 2025-08-19 17:24:59

Daiichi Sankyo Announces Breakthrough Therapy Designation For Ifinatamab Deruxtecan

(RTTNews) - Daiichi Sankyo announced that Ifinatamab deruxtecan has been granted Breakthrough Therapy Designation by the FDA for the treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy. The FDA g - 2025-08-18 08:36:51

The Zacks Analyst Blog Highlights Merck, Palo Alto Networks, Freeport-McMoRan and Espey

Analysts spotlight Merck, Palo Alto Networks, Freeport-McMoRan, and Espey as innovation, contract wins, and industry trends shape growth prospects. - 2025-08-15 12:44:00

Noteworthy ETF Outflows: SUSL, MCD, DIS, MRK

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares ESG MSCI USA Leaders ETF (Symbol: SUSL) where we have detected an approximate $84.6 million dollar outflow -- that's a 8.7% decrease week ov - 2025-08-15 11:49:25

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-15 10:31:59

Top Analyst Reports for Merck, Palo Alto & Freeport

Merck leans on Keytruda growth and pipeline expansion, Palo Alto rides subscription security demand, and Freeport benefits from electrification-driven copper demand. - 2025-08-14 17:46:00

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 15:15:33

MRK April 2026 Options Begin Trading

Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the April 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 246 days until expiration the newly available contra - 2025-08-14 14:30:24

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 14:05:26

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 12:17:47

iShares MSCI North America UCITS ETF USD (Dist) USD MRK holdings

Date	Number of MRK Shares Held	Base Market Value of MRK Shares	Local Market Value of MRK Shares	Change in MRK Shares Held	Change in MRK Base Value	Current Price per MRK Share Held	Previous Price per MRK Share Held
2025-11-27 (Thursday)	51,730	USD 5,412,510	USD 5,412,510	0	USD 0	USD 104.63	USD 104.63
2025-11-26 (Wednesday)	51,730	USD 5,412,510	USD 5,412,510	0	USD -53,282	USD 104.63	USD 105.66
2025-11-25 (Tuesday)	51,730	USD 5,465,792	USD 5,465,792	-334	USD 238,566	USD 105.66	USD 100.4
2025-11-24 (Monday)	52,064	USD 5,227,226	USD 5,227,226	0	USD 137,449	USD 100.4	USD 97.76
2025-11-21 (Friday)	52,064	USD 5,089,777	USD 5,089,777	0	USD 145,259	USD 97.76	USD 94.97
2025-11-20 (Thursday)	52,064	USD 4,944,518	USD 4,944,518	1,002	USD 91,075	USD 94.97	USD 95.05
2025-11-19 (Wednesday)	51,062	USD 4,853,443	USD 4,853,443	0	USD -70,466	USD 95.05	USD 96.43
2025-11-18 (Tuesday)	51,062	USD 4,923,909	USD 4,923,909	0	USD 182,292	USD 96.43	USD 92.86
2025-11-17 (Monday)	51,062	USD 4,741,617	USD 4,741,617	0	USD -3,575	USD 92.86	USD 92.93
2025-11-13 (Thursday)	51,062	USD 4,745,192	USD 4,745,192	0	USD 75,572	USD 92.93	USD 91.45

Share Trades of MRK by Blackrock for IE00B14X4M10

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-25	SELL	-334	105.840	100.705	101.219	GBX -33,807	87.60 Loss of -4,550 on sale
2025-11-20	BUY	1,002	96.000	93.900	94.110	GBX 94,298	87.44
2025-11-06	SELL	-334	86.170	84.350	84.532	GBX -28,234	87.26 Profit of 913 on sale
2025-11-03	SELL	-334	86.100	82.340	82.716	GBX -27,627	87.31 Profit of 1,534 on sale
2025-10-15	SELL	-668	84.690	83.610	83.718	GBX -55,924	87.35 Profit of 2,426 on sale
2025-10-02	SELL	-334	91.000	88.220	88.498	GBX -29,558	87.35 Loss of -383 on sale
2025-07-29	BUY	670	82.890	76.660	77.283	GBX 51,780	87.92
2025-06-26	SELL	-668	80.250	78.370	78.558	GBX -52,477	88.87 Profit of 6,885 on sale
2025-06-23	SELL	-334	80.220	78.990	79.113	GBX -26,424	89.06 Profit of 3,321 on sale
2025-06-17	SELL	-334	80.700	78.190	78.441	GBX -26,199	89.28 Profit of 3,621 on sale
2025-06-13	SELL	-334	82.440	81.450	81.549	GBX -27,237	89.40 Profit of 2,622 on sale
2025-06-10	SELL	-668	81.880	79.330	79.585	GBX -53,163	89.59 Profit of 6,684 on sale
2025-06-05	SELL	-334	78.550	77.250	77.380	GBX -25,845	89.85 Profit of 4,165 on sale
2025-06-04	BUY	334	79.140	77.330	77.511	GBX 25,889	89.94
2025-05-28	BUY	6,346	77.725	75.590	75.803	GBX 481,049	90.49
2025-05-20	SELL	-1,002	79.180	77.422	77.597	GBX -77,753	91.17 Profit of 13,597 on sale
2025-05-15	BUY	334			74.800*		91.57
2025-05-13	SELL	-334			76.630*		91.87 Profit of 30,686 on sale
2025-04-22	SELL	-334	79.035	77.660	77.798	GBX -25,984	93.59 Profit of 5,275 on sale
2025-03-10	SELL	-334			95.230*		96.78 Profit of 32,324 on sale
2025-03-07	SELL	-668			94.650*		96.81 Profit of 64,669 on sale
2025-03-05	SELL	-3,340			93.190*		96.87 Profit of 323,539 on sale
2025-03-04	SELL	-1,002			92.560*		96.94 Profit of 97,131 on sale
2025-02-26	SELL	-334	91.370	88.860	89.111	GBX -29,763	97.32 Profit of 2,743 on sale
2025-02-21	BUY	334	89.530	87.010	87.262	GBX 29,146	97.68
2025-01-02	BUY	1,670	100.350	98.840	98.991	GBX 165,315	102.08
2024-12-06	BUY	668	103.950	102.690	102.816	GBX 68,681	102.03
2024-12-02	BUY	668	101.850	100.460	100.599	GBX 67,200	102.05
2024-11-29	SELL	-668	103.040	101.530	101.681	GBX -67,923	102.07 Profit of 259 on sale
2024-11-12	BUY	1,336	100.760	98.500	98.726	GBX 131,898	103.64

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRK

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.